The biologic therapeutics market size has the potential to grow by USD 190.94 billion during 2020-2024, and the market’s growth momentum will accelerate during the forecast period. Major factors responsible for the growth of the market include technological advancements, rising prevalence of cancer, and increasing collaborations among market players for the development of next-generation antibody therapeutics. Moreover, improving life sciences research infrastructure, increasing applications of such therapies, and government support for related research are playing a pivotal role in the growth of the market.